1244-58-2

Basic information

• Product Name: cannabidiolic acid
• Synonyms: cannabidiolic acid;2,4-Dihydroxy-3-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-6-pentylbenzoic acid;2,4-Dihydroxy-3-[(1R,6R)-3-methyl-6-isopropenyl-2-cyclohexenyl]-6-pentylbenzoic acid;2,4-dihydroxy-3-[(1R,6R)-3-methyl-6-prop-1-en-2-yl-cyclohex-2-en-1-yl]-6-pentyl-benzoic acid;2,4-dihydroxy-3-[(1R,6R)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]-6-pentylbenzoic acid;6-amyl-2,4-dihydroxy-3-[(1R,6R)-6-isopropenyl-3-methyl-cyclohex-2-en-1-yl]benzoic acid;Cannabidiolic Acid (CRM)
• CAS NO: 1244-58-2
• Molecular Formula: C₂₂H₃₀O₄
• Molecular Weight: 358.47
• Mol File: 1244-58-2.mol
• Article Data: 12

Chemical Properties

• Melting Point: 45-48 °C
• Boiling Point: 530.8°Cat760mmHg
• Flash Point: 2℃
• Appearance: /
• Density: 1.123g/cm³
• Vapor Pressure: 4.27E-12mmHg at 25°C
• Refractive Index: 1.564
• Storage Temp.: −20°C
• PKA: 3.41±0.43(Predicted)
• CAS DataBase Reference: cannabidiolic acid(CAS DataBase Reference)
• NIST Chemistry Reference: cannabidiolic acid(1244-58-2)
• EPA Substance Registry System: cannabidiolic acid(1244-58-2)

Safety Data

• RIDADR: UN 1648 3 / PGII
• WGK Germany: 3
• Hazardous Substances Data: 1244-58-2(Hazardous Substances Data)

Usage

Description

Cannabidiolic acid (CBDA) is a naturally occurring phytocannabinoid found in fiber-type cannabis plants. It is produced through the enzymatic conversion of cannabigerolic acid by cannabidiolic acid synthase. CBDA is a dihydroxybenzoic acid derivative with a unique structure, featuring a 3-p-mentha-1,8-dien-3-yl (limonene) group substitution at the hydrogen position 3. cannabidiolic acid is primarily used for research and forensic applications, and it holds potential therapeutic value in the medical field.

Uses

Used in Pharmaceutical Industry:
Cannabidiolic acid is used as a therapeutic agent for its potential value in the treatment of aggressive breast cancers. It acts as an inhibitor of MDA-MB-231 breast cancer cell migration, which can help in the abrogation of cancer cell migration and the management of aggressive breast cancers.
Used in Research and Forensic Applications:
Cannabidiolic acid serves as a certified reference material for research purposes, aiding in the study of its properties, mechanisms of action, and potential applications in the medical and pharmaceutical fields. It is also utilized in forensic applications for the identification and analysis of cannabinoids in various samples.

InChI:InChI=1/C22H30O4/c1-5-6-7-8-15-12-18(23)20(21(24)19(15)22(25)26)17-11-14(4)9-10-16(17)13(2)3/h11-12,16-17,23-24H,2,5-10H2,1,3-4H3,(H,25,26)/t16-,17+/m0/s1

Upstream product

• 491-72-5 2,4-dihydroxyl-6-pentylbenzoic acid 
• 25555-57-1 CBGA 
• 13956-29-1 CBD 
• 4861-79-4 magnesium methyl carbonate 
• 58016-28-7 methyl 2,6-dihydroxy-6-pentylbenzoate 
• 55658-71-4 methyl (1'R,2'R)-2,6-dihydroxy-5'-methyl-4-pentyl-2'-(prop-1 -en-2- yl)-1',2',3',4'-tetrahydro-[1,1'-biphenyl]-3-carboxylate 
• 14171-36-9 methyl magnesium carbonate 
• 25654-31-3 2-[(2E)-3,7-dimethylocta-2,6-dienyl]-5-pentyl-benzene-1,3-diol 
• 106-24-1 Geraniol 
• 500-66-3 Olivetol 
• 763-10-0 geranyl diphosphate 

Downstream Products

• 1040411-85-5 phenethyl 2,4-dihydroxy-3-((1R,6R)-3-methyl-6-(prop-1-en-2-yl)cyclohex-2-enyl)-6-pentylbenzoate 
• 13956-29-1 CBD 
• 1972-08-3 dronabinol 
• 2808-39-1 cannabinolic acid 
• 521-35-7 cannabinol 

Relevant articles and documents

CANNABINOID ACID ESTER COMPOSITIONS AND USES THEREOF

The present disclosure provides pharmaceutical compositions including a cannabinoid acid ester compound alone or in combination with one or more additional cannabinoid compounds. In some embodiments, the cannabinoid acid ester compound is a tetrahydrocann

CANNABIDIOLIC ACID ESTERS FOR TREATING MUSCULAR DYSTROPHY

The present invention provides compositions and methods for treating muscular dystrophy. In particular, the present invention provides pharmaceutical compositions and formulations comprising a cannabidiolic acid (CBDA) ester alone or in combination with o

CANNABIDIOLIC ACID (CBDA) DERIVATIVES AND USES THEREOF

The present invention provides novel compounds comprising cannabidiolic acid (CBDA) derivatives, including acids and esters, and uses thereof in the treatment of various diseases, disorders, conditions and symptoms.